Robert Alexander Ingram, Director at Valeant Pharmaceuticals International, Inc. (VRX), sold 9,872 shares at $40.00 ($395K) on 2011-02-28, disclosed to the SEC on 2011-03-03.
Open-market sale of $395k VRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NOVN | BUY | 2019-05-23 | $111K | — | Filing → |
| NOVN | BUY | 2018-10-01 | $142K | — | Filing → |
| NOVN | BUY | 2017-08-29 | $55K | — | Filing → |